Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology

NCT02516046 is registered in ClinicalTrials.gov with Avid Radiopharmaceuticals as lead sponsor.

NCT NCT02516046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02516046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Lead sponsor
Avid Radiopharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2015
Completion date
July 15, 2018
Enrollment
156 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease